Anthony P. Adamis - Jun 23, 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/27/2022, 04:38 PM
Next filing
Jun 22, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +6K $0.00 6K Jun 23, 2022 Common Stock 6K $0.00 Direct F1
transaction EYPT Stock Option (Right to Buy) Award $0 +22K $0.00 22K Jun 23, 2022 Common Stock 22K $7.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest in three equal annual installments beginning June 23, 2023.
F2 The option becomes exercisable in three ratable annual installments beginning on June 23, 2023.